ABSTRACT
BACKGROUND: Homeopathy is frequently and successfully used in daily clinical practice, so there is a need for well-documented case reports that illustrate its effectiveness. For this reason, we present a case in which homeopathy was used to treat an ankle and lower leg for spontaneous acute swelling and redness. CASE REPORT: A 54-year-old man presented with recurrence of a swollen left ankle and lower leg, which had previously been treated by conventional medicine. After case taking, a homeopathic treatment with Apis mellifica 200c led to a fast improvement. The patient was free of symptoms within 24 hours and has remained so for 3 years. CONCLUSION: Homeopathic treatment with Apis mellifica led to a fast and long-lasting improvement of an acute ankle swelling and reddening that had recurred after conventional medical therapy of similar symptoms.
Subject(s)
Edema/drug therapy , Leg/abnormalities , Materia Medica/therapeutic use , Humans , Leg/physiopathology , Male , Materia Medica/standards , Middle AgedABSTRACT
BACKGROUND AND AIM: This preliminary study aimed to evaluate whether a homeopathic preparation (Traumeel S) might be a good option to control post-operative outcomes (pain, edema and trismus) associated with surgical removal of mandibular third molar teeth. The null hypothesis was that Traumeel S is not different from dexamethasone (gold standard) in controlling these post-operative inflammatory complications. METHODS: A randomized, "split-mouth", triple-blind clinical trial was conducted. Seventeen healthy patients with a mean age of 20.94 ( ± 5.83) years had their lower asymptomatic bilateral third molars removed. Patients were randomized to receive Traumeel S or dexamethasone pre-operatively by injection into the masseter muscle; each patient acted as his/her own control. At 24, 48, 72 hours and 7 days after the surgery, the pain was evaluated according to a visual analog scale, edema through linear measurements of the face, and trismus through the maximum buccal opening. Wilcoxon statistics or paired t-test were used, and a significance level of 95% was adopted. RESULTS: For pain, the results for Traumeel S were not different (p > 0.05) from those of dexamethasone after 24 hours, 72 hours, and 7 days. For edema, the results for Traumeel S were not different (p > 0.05) from those of dexamethasone at all post-operative evaluations. For mouth opening, the results for Traumeel S were not different (p > 0.05) from those of dexamethasone at 72 hours and 7 days after third molar extraction. CONCLUSION: With the exception of some early post-operative findings, the null hypothesis is not rejected. Traumeel S might be a good alternative approach to dexamethasone for controlling pain, edema and trismus after third molar removal.
Subject(s)
Homeopathy , Tooth, Impacted , Adult , Anti-Inflammatory Agents/therapeutic use , Dexamethasone/therapeutic use , Double-Blind Method , Edema/drug therapy , Female , Humans , Male , Minerals , Molar, Third/surgery , Pain, Postoperative/drug therapy , Plant Extracts , Prospective Studies , Tooth, Impacted/surgery , Young AdultABSTRACT
INTRODUCTION: Arnica and bromelain, two of the most widely recommended homeopathic medications to improve perioperative outcomes, have yet to be widely adopted by allopathic practitioners. A significant barrier to utilization of herbal medications by allopathic doctors is that the preparations and dosing regimens are not widely known or understood. The goal of this review was to critically analyze studies that have examined the perioperative efficacy of arnica and bromelain with a focus on treatment regimen and outcomes. METHODS: A triple database search was conducted with the keywords "arnica," "bromelain," and "surgery." References for each identified article were analyzed for additional articles. Articles were analyzed for methodology, outcomes, and conclusion. Articles were excluded if they did not involve human subjects, were published before 1990, and if they were not available in English. Level of evidence was determined based on methodology. RESULTS: A total of 29 articles met inclusion criteria, with 20 and 9 in the arnica and bromelain treatment groups, respectively. There was marked heterogeneity with regard to surgical procedure, dosing regimen, outcomes measured, and results. Arnica seems to have a mitigating effect on ecchymosis, most notably following rhinoplasty and facelifts/facial procedures. Bromelain is well supported across numerous studies in reducing trismus, pain, and swelling following molar extractions. However, there was no effect demonstrated when evaluating topical arnica following blepharoplasty procedures. DISCUSSION: A systematic review of the literature demonstrates the potential for arnica and bromelain to improve perioperative outcomes including edema, ecchymosis, and pain control. Future studies are required to determine safety and efficacy of dosing and interactions with other medications. We hope this article stimulates surgeons to consider using these interventions to improve perioperative outcomes in the context of well-done studies with an objective analysis of results.
Subject(s)
Arnica , Bromelains/therapeutic use , Homeopathy/methods , Plant Extracts/therapeutic use , Postoperative Complications/prevention & control , Edema/drug therapy , Edema/prevention & control , Humans , Postoperative Complications/drug therapy , Treatment OutcomeABSTRACT
OBJECTIVE: To assess the effect of Symphytum 5CH on the postoperative pain and swelling after placement of a titanium dental implant. MATERIAL AND METHODS: Data on pain and swelling following pure titanium implants were reviewed. Patients were treated postoperatively with ketoprofen only or ketoprofen and Symphytum 5CH, according to the treating dentist's usual practice. Demographics and baseline characteristics were recorded and compared. Pain and swelling were compared between the two treatment groups using the Wilcoxon rank sum test and ordinal logistic regression, estimating odds ratios and confidence intervals. RESULTS: 100 implants in 57 patients (28 males, 29 females) were treated with ketoprofen alone; 100 implants in 60 patients (14 males, 46 females) with ketoprofen and Symphytum. The group treated with ketoprofen and Symphytum appeared to have a better response in terms of both pain and swelling. Ordinal logistic regression: pain 0.23, 95% CI 0.13-0.41; swelling 0.24, 95% CI 0.13-0.44. Correction for demographics and implant characteristics greatly widened the confidence intervals so that the results were no longer statistically significant (pain: OR = 0.15, 95% CI 0.07-34.56; swelling OR = 0.18, 95% CI 0.07-46.78). CONCLUSIONS: Adding Symphytum 5CH to conventional analgesia may reduce pain and swelling after minor dental implant surgery. No firm conclusion can be drawn since the results are confounded by baseline differences, principally gender. Further, randomized, studies should be conducted.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Dental Implants/adverse effects , Edema/drug therapy , Facial Pain/drug therapy , Homeopathy/methods , Ketoprofen/administration & dosage , Adult , Aged , Comfrey , Confidence Intervals , Drug Therapy, Combination , Edema/etiology , Facial Pain/etiology , Female , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Pain Measurement , Pain, Postoperative/drug therapy , Plant Extracts/administration & dosage , Treatment OutcomeABSTRACT
BACKGROUND: Frog skin has been sequentially and scientifically evaluated by our group for its wound healing efficiency. Owing to the complex structure of skin, attempts were being made to analyse the role of individual constituents in different phases of healing. Our earlier papers have shown the significance of frog skin not only in wound healing but also enhancing the proliferating activity of the epidermal and dermal cells which are instrumental for normal healing process. We also have identified for the first time novel antimicrobial peptides from the skin of Rana tigerina and thereby reduce the complications involved in the sepsis. PURPOSE OF THE STUDY AND RESULTS: The current study envisages the role of frog skin lipids in the inflammatory phase of wound healing. The lipid moiety of the frog skin dominated by phospholipids exhibited a dose dependent acceleration of healing irrespective of the mode of application. The efficiency of the extract is attributed partially to the anti-inflammatory activity as observed by the histochemical and immunostimulatory together with plethysmographic studies. CONCLUSIONS: Thus, frog skin for the first time has been demonstrated to possess lipid components with pharmaceutical and therapeutic potential. The identification and characterization of such natural healing molecules and evaluating their mechanism of action would therefore provide basis for understanding the cues of Nature and hence can be used for application in medicine.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Lipids/therapeutic use , Materia Medica , Ranidae , Skin/chemistry , Skin/drug effects , Tissue Extracts/therapeutic use , Wound Healing/drug effects , Administration, Cutaneous , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/analysis , Anti-Inflammatory Agents, Non-Steroidal/immunology , Dose-Response Relationship, Drug , Drug Discovery , Edema/chemically induced , Edema/drug therapy , Female , Granulation Tissue/chemistry , Granulation Tissue/drug effects , Hypersensitivity/drug therapy , Hypersensitivity/immunology , Immunity, Humoral/drug effects , India , Injections, Intraperitoneal , Lipids/administration & dosage , Lipids/analysis , Lipids/immunology , Medicine, Traditional , Rats , Rats, Wistar , Skin/injuries , Tissue Extracts/administration & dosage , Tissue Extracts/chemistry , Tissue Extracts/immunologyABSTRACT
BACKGROUND: Toxicodendron pubescens is the current botanical name of homeopathic Rhus toxicodendron (Rhus tox). Rhus tox drug is widely used in homeopathically diluted form in the treatment of inflammatory and edematous conditions. We studied the effect of crude form of this plant, after single and multiple doses in Carrageenan induced paw inflammation in rats. METHOD: We evaluated effects of single dose and multiple doses of orally administered Rhus tox on Carrageenan induced paw inflammation in rats. We tested 10 mg/kg, 20 mg/kg and 40 mg/kg doses of Rhus tox. In the single dose study, Rhus tox was administered 1 h prior to the subplantar injection of Carrageenan. In the multiple dose study, Rhus tox was administered twice daily for three days and Carrageenan was injected 1 h after the last dose. Paw volume was measured using a digital plethysmometer. RESULTS: Administration of a single dose of Rhus tox 1h prior to injection of Carrageenan significantly reduced the paw inflammation in a dose dependent manner. Administration of multiple doses of Rhus tox increased the intensity of inflammation induced by Carrageenan, but this was not statistically significant. CONCLUSION: Rhus tox, in crude form, exerts anti-inflammatory effects after a single dose and proinflammatory effect after multiple doses in Carrageenan induced paw inflammation in rats. Further study is needed to explain this dual effect.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Edema/drug therapy , Homeopathy , Toxicodendron , Animals , Carrageenan , Dose-Response Relationship, Drug , Edema/chemically induced , Male , Mice , Rats , Rats, WistarABSTRACT
The Similia Principle, the basis of homeopathy, implies that substances initiating symptoms when applied to healthy biological systems can be utilized as remedies to treat a diseased system with similar symptoms. Depending whether the remedy substance was of the same type as the etiologic agent, treatment is classified as either homologous or heterologous. The intact rat is the biological system most utilized in basic science homeopathic research. The Homeopathy Basic Research experiments (HomBRex) database (about 1300 experiments on model biological systems in homeopathic research) was analyzed for homologous and heterologous treatments of disease states of intact rats. The relationship between the Similia Principle and hormesis is discussed.
Subject(s)
Disease Models, Animal , Homeopathy/methods , Phytotherapy , Animals , Behavior, Animal/drug effects , Databases, Bibliographic , Edema/drug therapy , Hormone Replacement Therapy , Inflammation/drug therapy , Poisoning/drug therapy , RatsABSTRACT
OBJECTIVE: To research the effects of Alligator Zhikegao on relieving cough, dispelling phlegm and anti-inflammation. METHOD: The coughing tests in mice, the phenol red secreting tests in mice, ear edema tests in mice,and paw edema tests and subcutaneous cotton ball granuloma in rats were adopted for observing the related pharmacological effects of Alligator Zhikegao. RESULT: Alligator Zhikegao could obviously prolong the latent period and decrease the times of mouse coughing, and remarkably inhibit the mouse ear edema (P < 0.001), the rat paw edema and the hyperplasia of subcutaneous cotton ball granuloma in rats. Alligator Zhikegao 11.70 g x kg(-1) could significant improve the carbonic clearances of macrophages (P <0.05) and the hemolysin level in serum (P <0.01). CONCLUSION: Alligator Zhikegao has significant effects on relieving cough, dispelling phlegm, anti-inflammation and immunological regulation.
Subject(s)
Alligators and Crocodiles , Antitussive Agents/therapeutic use , Expectorants/therapeutic use , Glycosaminoglycans/therapeutic use , Materia Medica/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antitussive Agents/isolation & purification , Cough/drug therapy , Drug Combinations , Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/therapeutic use , Ear Diseases/drug therapy , Edema/drug therapy , Expectorants/isolation & purification , Female , Glycosaminoglycans/isolation & purification , Granuloma/drug therapy , Male , Materia Medica/isolation & purification , Medicine, Chinese Traditional , Mice , Plants, Medicinal/chemistry , Random Allocation , Rats , Rats, Sprague-DawleyABSTRACT
OBJECTIVES: We investigated the effectiveness of homeopathic Arnica montana on postoperative swelling and pain after arthroscopy (ART), artificial knee joint implantation (AKJ), and cruciate ligament reconstruction (CLR). DESIGN: Three randomised, placebo-controlled, double-blind, sequential clinical trials. SETTING: Single primary care unit specialised in arthroscopic knee surgery. PARTICIPANTS: Patients suffering from a knee disease that necessitated arthroscopic surgery. INTERVENTIONS: Prior to surgery, patients were given 1 x 5 globules of the homeopathic dilution 30x (a homeopathic dilution of 1:10(30)) of arnica or placebo. Following surgery, 3 x 5 globules were administered daily. PRIMARY OUTCOME MEASURES: The primary outcome parameter was difference in knee circumference, defined as the ratio of circumference on day 1 (ART) or day 2 (CLR and AKJ) after surgery to baseline circumference. RESULTS: A total of 227 patients were enrolled in the ART (33% female, mean age 43.2 years;), 35 in the AKJ (71% female, 67.0 years), and 57 in the CLR trial (26% female; 33.4 years). The percentage of change in knee circumference was similar between the treatment groups for ART (group difference Delta=-0.25%, 95% CI: -0.85 to 0.41, p=0.204) and AKJ (Delta=-1.68%, -4.24 to 0.77, p=0.184) and showed homeopathic arnica to have a beneficial effect compared to placebo in CLR (Delta=-1.80%, -3.30 to -0.30, p=0.019). CONCLUSIONS: In all three trials, patients receiving homeopathic arnica showed a trend towards less postoperative swelling compared to patients receiving placebo. However, a significant difference in favour of homeopathic arnica was only found in the CLR trial.
Subject(s)
Arnica , Homeopathy/methods , Knee Joint/surgery , Orthopedic Procedures/adverse effects , Adult , Aged , Double-Blind Method , Edema/drug therapy , Female , Humans , Male , Middle Aged , Pain, Postoperative/drug therapyABSTRACT
A study was conducted on the pharmacological actions of the toad venom-containing drug "Kyushin" (KY-2 and KY-R) on urinary volume and electrolytes excretion, regional blood flow, renal artery blood flow and carrageenin-induced hind-paw edema. In rabbits, KY-2 and KY-R significantly increased urinary volume after intravenous administration of 8 mg/kg. In guinea pigs, KY-2 and KY-R produced a significant increase in urinary volume after intraduodenal administration (i.d.) of 80 mg/kg. In guinea pigs treated with propranolol, KY-2 at 20 and 40 mg/kg p.o. and KY-R at 40 mg/kg p.o. increased urinary volume. At 40 mg/kg i.d. both KY-2 and KY-R produced an increase in regional blood flow, as determined by the hydrogen gas clearance method, of the brain areas including the amygdaloid nucleus, but did not affect regional blood flow in liver, kidney and skeletal muscle, or renal artery blood flow. In rats, carrageenin-induced hind-paw edema was inhibited by KY-2 or KY-R at 600 mg/kg p.o.
Subject(s)
Bufanolides/pharmacology , Edema/drug therapy , Electrolytes/urine , Hemodynamics/drug effects , Materia Medica/pharmacology , Renal Circulation/drug effects , Urine , Animals , Carrageenan , Digoxin/pharmacology , Drug Evaluation, Preclinical , Duodenum , Edema/chemically induced , Guinea Pigs , Injections, Intravenous , Intubation, Gastrointestinal , Liver/blood supply , Male , Muscles/blood supply , Propranolol/pharmacology , Rabbits , Rats , Rats, Wistar , Renal Artery/physiologyABSTRACT
An anti-inflammatory compound was purified and isolated from pilose antler of Cervus nippon Temminck by dialysis, gel filtration and ion-exchange chromatography techniques. HPLC and N-terminal amion acid analysis identified the compound as a homogeneous peptide. The peptide is composed of 68 amino acids and its molecular weight as determined by amino analysis, is about 7200.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Antlers/chemistry , Deer , Materia Medica/chemistry , Peptides/isolation & purification , Amino Acids/analysis , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Edema/drug therapy , Peptides/chemistry , Peptides/therapeutic use , RatsABSTRACT
As a kind of anti-inflammatory protein fractionated and purified from the larva of parasa sinica, CCP (ip) has a significant anti-inflammatory effect on ear odema induced by croton oil in mice. Its ID50 is 1.6mg/kg, but a dose of 2.5mg/kg can also significantly inhibit the rat ankle odema induced by carrageenan and egg white.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Edema/drug therapy , Insect Hormones/therapeutic use , Materia Medica/therapeutic use , Moths , Animals , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Carrageenan , Croton Oil , Edema/chemically induced , Female , Insect Hormones/isolation & purification , Male , Materia Medica/chemistry , Mice , Mice, Inbred C57BL , Moths/chemistry , Ovalbumin , Rats , Rats, Sprague-DawleyABSTRACT
OBJECTIVE: To study the antiinflammatory effect of a compound TCM (Traditional Chinese Medicine) agent on animal models. The agent contains ant extractive and a blent of three herbal products, herba epimedii, fructus cnidii, and fructus lycii. METHOD: Three animal models to induce experimental inflammation in rats, including carrageenin--induced paw edema, cotton-ball granuloma and adjuvant induced arthritis, were chosen to study the antiinflammatory effect of the TCM agent. RESULT: The TCM agent showed a marked inhibitory effect on edema induced by all three types of inflammation in rats, the inhibitory rate of the TCM agent at the dose of 0.20, 0.40 and 0.80 g.kg-1 in granuloma model bing over 25% at 1 hour post oral administration, and being 23.8%, 22.7%, 39.7% at 6 hour. In addition, the TCM agent also showed a significant preventive as well as therapeutic effect on adjuvant induced arthritis in rats, and improved the pathological changes of the animal joints with the induced arthritis. CONCLUSION: TCM agent has significant antiinflammatory effects on the three above mentioned animal models.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Ants , Drugs, Chinese Herbal/therapeutic use , Edema/drug therapy , Materia Medica/therapeutic use , Animals , Arthritis/drug therapy , Capsules , Cnidium/chemistry , Drug Combinations , Drugs, Chinese Herbal/isolation & purification , Epimedium/chemistry , Granuloma, Foreign-Body/drug therapy , Lycium/chemistry , Male , Plants, Medicinal/chemistry , Rats , Rats, WistarABSTRACT
BACKGROUND: Homeopathic Rhus toxicodendron (Rhus tox) is used in various inflammatory conditions. We screened its effect compared to succussed ethanol controls and appropriate active controls. METHOD: We initially experimented with Rhus tox 6, 12, 30 and 200 cH, using carrageenan-induced paw oedema in rats. The 6 cH dilution appeared most effective and was used in subsequent assays. We used pre-treatment and single treatment regimes in Wistar rats, and mice. RESULTS: We found significant reductions compared to control in carrageenan-induced paw oedema, vascular permeability, writhing induced by intraperitoneal acetic acid and stress induced gastric lesions. CONCLUSIONS: Rhus tox in homeopathic dilution appears to interfere with inflammatory processes involving histamine, prostaglandins and other inflammatory mediators.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Edema/drug therapy , Foot Diseases/drug therapy , Homeopathy/methods , Phytotherapy , Rhus , Toxicodendron , Administration, Oral , Animals , Capillary Permeability/drug effects , Carrageenan , Disease Models, Animal , Dose-Response Relationship, Drug , Edema/chemically induced , Foot Diseases/chemically induced , Male , Mice , Pain/prevention & control , Pain Measurement , Rats , Rats, Wistar , Stomach Ulcer/prevention & controlABSTRACT
To evaluate the effect of Calotropis G in various experimental animal models. The anti-inflammatory activity was evaluated using carrageenin-induced kaolin -induced rat paw oedema for acute and cotton-pellet granuloma, adjuvant-induced arthritis model for chronic inflammation. Antipyretic activity was carried out using yeast induced pyresis method. Phenylquinone--induced writhing method in mice was used for analgesic activity. Test compounds exhibited variable anti-inflammatory activity and peak activity of the test compounds were reached at 2 h. Alkaloid fraction possesses comparatively high initial anti-inflammatory activity. The residual anti-inflammatory activity of alkaloid fraction of Calotropis G suggest either a greater protein binding nature of the compound there by providing a slow released pool of active drug molecule in the system or non available of possible bioactive metabolites to retain the activity profile relation.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Arthritis, Experimental/drug therapy , Calotropis , Edema/drug therapy , Inflammation/drug therapy , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/physiopathology , Chronic Disease , Edema/etiology , Homeopathy , Inflammation/etiology , Male , Mice , Models, Animal , Phenylbutazone/pharmacology , Phenylbutazone/therapeutic use , Plant Extracts/therapeutic use , RatsABSTRACT
Carrageenan oedema, a classical experimental model commonly used to test activity of anti-inflammatory drugs, was used to evaluate the therapeutic activity of a low-potency mineral complex (MC). The MC was administered in the right plantar surface of albino rats 60 min before, simultaneously and 30 min after injection of carrageenan, an irritant which causes a local, transitory increase of fluid volume. The administration of the MC 60 min before the injection of carrageenan primed the animal to enhanced inflammatory response to the irritant. The administration of MC contemporarily to carrageenan did not modify the kinetic and the extent of the oedema, while the administration of the MC 30 min after the induction of the oedema significantly reduced the early phase of the inflammatory reaction. This indicated that the therapeutic action of this MC is not due to conventional anti-inflammatory effect but to activation of endogenous regulatory mechanisms, a phenomenon which may be regarded as a simple application of the 'similia rule'.
Subject(s)
Anti-Inflammatory Agents/therapeutic use , Homeopathy , Inflammation/drug therapy , Minerals/therapeutic use , Animals , Carrageenan , Disease Models, Animal , Edema/chemically induced , Edema/drug therapy , Foot Diseases/chemically induced , Foot Diseases/drug therapy , Irritants , Male , Rats , Rats, Sprague-DawleyABSTRACT
The anti-inflammatory effect of Causticum was evaluated using acute and chronic inflammatory models in vivo. The administration of concentrated Causticum solution into the hind paw of rats produced an inflammatory reaction with oedema formation within the first hour, showing that Causticum acts as an oedematogenic agent. Carrageenin induced rat paw oedema was significantly inhibited (P<0.05) in the group treated with Causticum 30cH solution compared to control. Groups treated with potentized Causticum (6cH, 12cH, 30cH and 200cH), showed significant inhibition (P<0.05) of the inflammation pre-induced by carrageenin. However pre-treatment with Causticum 30cH for 6 days (0.5 ml, daily) did not significantly inhibit granulation using an implantation method.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Calcium Hydroxide/pharmacology , Edema/drug therapy , Foot Diseases/chemically induced , Inflammation/drug therapy , Phytotherapy , Plant Extracts/administration & dosage , Potassium Compounds/pharmacology , Animals , Calcium Hydroxide/administration & dosage , Carrageenan , Disease Models, Animal , Dose-Response Relationship, Drug , Edema/chemically induced , Granulation Tissue/drug effects , Inflammation/chemically induced , Male , Potassium Compounds/administration & dosage , Random Allocation , Rats , Rats, Wistar , Time FactorsABSTRACT
The anti-inflammatory effect of Arnica montana 6cH was evaluated using acute and chronic inflammation models. In the acute, model, carrageenin-induced rat paw oedema, the group treated with Arnica montana 6cH showed 30% inhibition compared to control (P < 0.05). Treatment with Arnica 6cH, 30 min prior to carrageenin, did not produce any inhibition of the inflammatory process. In the chronic model, Nystatin-induced oedema, the group treated 3 days previously with Arnica montana 6cH had reduced inflammation 6 h after the inflammatory agent was applied (P < 0.05). When treatment was given 6 h after Nystatin treatment, there was no significant inhibitory effect. In a model based on histamine-induced increase of vascular permeability, pretreatment with Arnica montana 6cH blocked the action of histamine in increasing vascular permeability.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Arnica , Edema/drug therapy , Foot Diseases/drug therapy , Inflammation/drug therapy , Phytotherapy , Plant Extracts/administration & dosage , Acute Disease , Analysis of Variance , Animals , Carrageenan , Chronic Disease , Disease Models, Animal , Dose-Response Relationship, Drug , Edema/chemically induced , Foot Diseases/chemically induced , Granulation Tissue/drug effects , Inflammation/chemically induced , Male , Nystatin , Random Allocation , Rats , Rats, Wistar , Time FactorsABSTRACT
AIM: To find the anti-inflammatory and anti-platelet aggregatory activity of human placental extract (HPE, Placentrex). METHODS: The HPE was studied for anti-inflammatory effect in Wistar rats on carrageenin, serotonin (5-HT), and prostaglandin E1 (PGE1) induced edema in acute model and cotton pellet induced granuloma on sub-acute model. Anti-platelet aggregation was studied against protection of adinosine diphosphate (ADP)-induced aggregation of human platelet through in vitro study. RESULTS: HPE showed positive results both in acute and sub-acute models of inflammation. Highly significant (P<0.01) results were obtained against 5-HT induced acute inflammation and cotton pellet induced sub-acute inflammation in comparison with standard (diclofenac sodium) and control (normal saline) drugs. The anti-inflammatory property of HPE in animal model was well supported with clinical study of platelet aggregation. There was highly significant (P<0.01) inhibition of platelet aggregation with HPE at different doses against ADP. CONCLUSION: Our data suggest that human placental extract may be useful in suppressing inflammation and platelet aggregation.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Inflammation/drug therapy , Materia Medica/pharmacology , Placental Extracts/pharmacology , Platelet Aggregation/drug effects , Animals , Edema/chemically induced , Edema/drug therapy , Humans , Inflammation/chemically induced , Male , Materia Medica/isolation & purification , Platelet Aggregation Inhibitors/pharmacology , RatsABSTRACT
Pilose antler peptide (PAP:MW:7200; amino acid residue:68) isolated from the antlers of Cervus nippon temminck 10 and 20 mg.kg-1 i.p. produced inhibitions towards acute and chronic inflammations in a dose-dependent manner. PAP reduced ascorbic acid and cholesterol contents in adrenal glands and decreased the serum hydrocortisone level of rats. The reduction of ascorbic acid and cholesterol contents were unaffected by the pretreatment of dexamethasone. PAP also showed an anti-inflammatory action on the swelling of carrageenan-induced hind paw in adrenalectomized rats. The results suggest that the anti-inflammatory effects of PAP do not depend absolutely on pituitary-adrenal system.